IA
VRTX icon

Icon Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Icon Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,506
Closed -$2.18M – 237
2020
Q2 		$2.18M Sell
7,506
-3,904
-34% -$1.06M 0.43% 84
2020
Q1 		$2.71M Hold
11,410
– – 0.59% 56
2019
Q4 		$2.5M Hold
11,410
– – 0.36% 97
2019
Q3 		$1.93M Sell
11,410
-4,400
-28% -$778K 0.29% 124
2019
Q2 		$2.9M Sell
15,810
-10,320
-39% -$1.8M 0.27% 96
2019
Q1 		$4.81M Hold
26,130
– – 0.48% 60
2018
Q4 		$4.33M Hold
26,130
– – 0.46% 67
2018
Q3 		$5.04M Sell
26,130
-680
-3% -$121K 0.43% 68
2018
Q2 		$4.56M Sell
26,810
-26,253
-49% -$4.07M 0.34% 80
2018
Q1 		$8.65M Hold
53,063
– – 0.65% 53
2017
Q4 		$7.95M Sell
53,063
-1,400
-3% -$207K 0.55% 64
2017
Q3 		$8.28M Buy
54,463
+26,253
+93% +$3.95M 0.58% 49
2017
Q2 		$3.63M Sell
28,210
-26,400
-48% -$3.18M 0.25% 129
2017
Q1 		$5.97M Buy
54,610
+27,000
+98% +$2.38M 0.41% 83
2016
Q4 		$2.03M Sell
27,610
-8,400
-23% -$683K 0.14% 199
2016
Q3 		$3.14M Buy
36,010
+28,910
+407% +$2.73M 0.21% 156
2016
Q2 		$611K Buy
+7,100
New +$613K 0.04% 302

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Icon Advisers's VRTX Position: Q3 2020 in Review

Icon Advisers sold out of Vertex Pharmaceuticals (VRTX) in Q3 2020, closing a stake of 7,506 shares — an estimated $2.18M sold.

Icon Advisers first reported a position in VRTX in Q2 2016 and held it in 17 quarters. The position peaked at $8.65M in Q1 2018. 951 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

  • Icon Advisers reported no remaining Vertex Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Icon Advisers sold 7,506 Vertex Pharmaceuticals shares in Q3 2020, an estimated $2.18M.
  • Icon Advisers first reported a position in Vertex Pharmaceuticals in Q2 2016 and held it in 17 quarters.
  • Icon Advisers's Vertex Pharmaceuticals position peaked at $8.65M in Q1 2018.
  • 951 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Icon Advisers's 13F filing for Q3 2020, filed 5 Nov 2020.